GSR IV Acquisition GSRFR
NASDAQ GSRFR
$1.20 -0.55 (-31.43%)
At close: Aug 19, 2026 · 4:00 PM EDT

GSR IV Acquisition (GSRFR) Cash & Equivalents (2025 - 2026)

GSR IV Acquisition (GSRFR) posted Cash & Equivalents of $810597.0 for Q1 2026, down 47.71% sequentially from $1.6 million in Q4 2025.

GSR IV Acquisition (GSRFR) Cash & Equivalents (2025 - 2026) Analysis & Trends

GSR IV Acquisition has reported Cash & Equivalents for 2 years, with the latest figure at $810597.0 in Q1 2026.

  • Quarterly Cash & Equivalents changed N/A year-over-year to $810597.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $810597.0 (changed N/A YoY) and the FY2025 annual result came in at $1.6 million, changed N/A from the prior year.
  • Cash & Equivalents eased to $810597.0 in Q1 2026 per GSRFR's latest filing, from $1.6 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $1.8 million in Q3 2025 and troughed at $810597.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Oxley Bridge Acquisition 585.76 Mn 585.76 Mn - 816,134.00
2 Launch Two Acquisition 557.86 Mn 557.86 Mn - 250,000.00
3 Drugs Made In America Acquisition 507.00 Mn 507.00 Mn - 174,974.00
4 Cantor Equity Partners IV 468.00 Mn 468.00 Mn - 25,000.00
5 GP-Act III Acquisition 401.06 Mn 401.06 Mn - 10,586.00
6 Aldel Financial 397.49 Mn 397.49 Mn - 283,112.00
7 Republic Digital Acquisition 389.25 Mn 388.51 Mn - 735,027.00
8 Gores Holdings X 385.06 Mn 384.87 Mn - 194,541.00
9 Agriculture & Natural Solutions Acquisition 377.29 Mn 377.04 Mn - 250,000.00
10 GSR IV Acquisition 27.60 Mn 27.60 Mn - 643,331.00

Historic Data

Download Data
DateValue
Mar 31, 2026 810,597.00
Dec 31, 2025 1.55 Mn
Sep 30, 2025 1.84 Mn